3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
4
Lymphoid
4
Myeloid
3
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
4
Colorectal Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Therapeutics
6
Flow Cytometry
5
Cyclophosphamide
5
Filgrastim
4
Radiotherapy
3
Psychiatric Rehabilitation
3
Polymerase Chain Reaction
3
Peripheral Blood Stem Cell Transplantation
3
Immunoenzyme Techniques
3
sargramostim
2
liposomal amphotericin B
2
aldesleukin
2
Vorinostat
2
Stem Cell Factor
2
Ondansetron
2
Mycophenolic Acid
2
Methylprednisolone
2
Itraconazole
2
Ipilimumab
2
Immunologic Techniques
2
Doxorubicin
2
Dexamethasone
2
Caspofungin
2
Capecitabine
2
Calcium Dobesilate
2
CTLA-4 Antigen
2
Bortezomib
2
Aprepitant
2
Antilymphocyte Serum
2
Amplified Fragment Length Polymorphism Analysis
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Immunotherapy
×
Breast
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled